Concepedia

Gérald Jesson

GJ

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2023

Affiliations

Immune Therapy Holdings (Sweden)(Current)

Gérald Jesson is an author at Immune Therapy Holdings (Sweden).

Publications per year

2023–2023

1

Publications

1

Despite warnings, co‐medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but <scp>XS004</scp>, a novel oral dasatinib formulation, provides reduced <scp>pH‐dependence</scp>, minimizing undesirable <scp>drug–drug</scp> interactions

Gunnar Larfors, Per Andersson, Gérald Jesson et al. · European Journal Of Haematology · 2023 · 10 citations · Full text

1–1 of 1